title: Inhaled multiwalled carbon nanotubes potentiate airway fibrosis in murine allergic asthma.
abstract: Carbon nanotubes are gaining increasing attention due to possible health risks from occupational or environmental exposures. This study tested the hypothesis that inhaled multiwalled carbon nanotubes (MWCNT) would increase airway fibrosis in mice with allergic asthma. Normal and ovalbumin-sensitized mice were exposed to a MWCNT aerosol (100 mg/m(3)) or saline aerosol for 6 hours. Lung injury, inflammation, and fibrosis were examined by histopathology, clinical chemistry, ELISA, or RT-PCR for cytokines/chemokines, growth factors, and collagen at 1 and 14 days after inhalation. Inhaled MWCNT were distributed throughout the lung and found in macrophages by light microscopy, but were also evident in epithelial cells by electron microscopy. Quantitative morphometry showed significant airway fibrosis at 14 days in mice that received a combination of ovalbumin and MWCNT, but not in mice that received ovalbumin or MWCNT only. Ovalbumin-sensitized mice that did not inhale MWCNT had elevated levels IL-13 and transforming growth factor (TGF)-beta1 in lung lavage fluid, but not platelet-derived growth factor (PDGF)-AA. In contrast, unsensitized mice that inhaled MWCNT had elevated PDGF-AA, but not increased levels of TGF-beta1 and IL-13. This suggested that airway fibrosis resulting from combined ovalbumin sensitization and MWCNT inhalation requires PDGF, a potent fibroblast mitogen, and TGF-beta1, which stimulates collagen production. Combined ovalbumin sensitization and MWCNT inhalation also synergistically increased IL-5 mRNA levels, which could further contribute to airway fibrosis. These data indicate that inhaled MWCNT require pre-existing inflammation to cause airway fibrosis. Our findings suggest that individuals with pre-existing allergic inflammation may be susceptible to airway fibrosis from inhaled MWCNT.
authors.affiliation: North Carolina State University, Box 7633, Raleigh, NC 27695, USA.
authors.forename: Jessica P
authors.initials: JP
authors.lastname: Ryman-Rasmussen
authors.forename: Earl W
authors.initials: EW
authors.lastname: Tewksbury
authors.forename: Owen R
authors.initials: OR
authors.lastname: Moss
authors.forename: Mark F
authors.initials: MF
authors.lastname: Cesta
authors.forename: Brian A
authors.initials: BA
authors.lastname: Wong
authors.forename: James C
authors.initials: JC
authors.lastname: Bonner
mesh_terms: D000280:Administration, Inhalation; D000336:Aerosols; D000818:Animals; D001249:Asthma / Q000139:chemically induced / Q000276:immunology / Q000473:pathology; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D005355:Fibrosis / Q000139:chemically induced / Q000276:immunology / Q000473:pathology; D006801:Humans; D018793:Interleukin-13 / Q000276:immunology; D008168:Lung / Q000166:cytology / Q000276:immunology / Q000473:pathology*; D008264:Macrophages / Q000166:cytology / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D037742:Nanotubes, Carbon / Q000009:adverse effects* / Q000648:ultrastructure; D010047:Ovalbumin / Q000276:immunology; D010316:Particle Size; D010982:Platelet-Derived Growth Factor / Q000276:immunology; D011897:Random Allocation; D053773:Transforming Growth Factor beta1 / Q000276:immunology
chemical_list: D000336:Aerosols; D018793:Interleukin-13; D037742:Nanotubes, Carbon; D010982:Platelet-Derived Growth Factor; D053773:Transforming Growth Factor beta1; C075278:platelet-derived growth factor A; D010047:Ovalbumin
references.citation: Am J Respir Crit Care Med. 1997 Apr;155(4):1376-83
references.pmid: 9105082
references.citation: Curr Opin Immunol. 2007 Dec;19(6):676-80
references.pmid: 17720466
references.citation: Am J Respir Cell Mol Biol. 2008 Jul;39(1):45-52
references.pmid: 18276795
references.citation: Clin Immunol. 2006 Nov;121(2):227-35
references.pmid: 16979384
references.citation: Toxicol Sci. 2008 Jan;101(1):179-80; author reply 181-2
references.pmid: 17897971
references.citation: Environ Toxicol. 2007 Aug;22(4):415-21
references.pmid: 17607736
references.citation: Toxicol Appl Pharmacol. 2005 Sep 15;207(3):221-31
references.pmid: 16129115
references.citation: J Allergy Clin Immunol. 2005 Mar;115(3):534-40
references.pmid: 15753901
references.citation: J Clin Invest. 2003 Oct;112(7):1029-36
references.pmid: 14523040
references.citation: Toxicology. 2008 Apr 18;246(2-3):124-31
references.pmid: 18289765
references.citation: Am J Physiol Lung Cell Mol Physiol. 2008 Jan;294(1):L87-97
references.pmid: 18024722
references.citation: Curr Opin Chem Biol. 2005 Dec;9(6):674-9
references.pmid: 16233988
references.citation: Toxicol Sci. 2006 Jul;92(1):5-22
references.pmid: 16484287
references.citation: Cytokine Growth Factor Rev. 2004 Aug;15(4):255-73
references.pmid: 15207816
references.citation: Inhal Toxicol. 2000 Jan-Feb;12(1-2):19-57
references.pmid: 10715617
references.citation: J Clin Invest. 2004 Feb;113(4):551-60
references.pmid: 14966564
references.citation: Nat Nanotechnol. 2008 Jul;3(7):423-8
references.pmid: 18654567
references.citation: J Immunol. 2006 Sep 15;177(6):4141-8
references.pmid: 16951379
references.citation: Science. 1998 Dec 18;282(5397):2258-61
references.pmid: 9856949
references.citation: Respir Res. 2005 Sep 16;6:106
references.pmid: 16164761
references.citation: J Pathol. 2008 Jan;214(2):199-210
references.pmid: 18161745
references.citation: Am J Physiol Lung Cell Mol Physiol. 2005 Nov;289(5):L698-708
references.pmid: 15951334
references.citation: J Toxicol Environ Health A. 2004 Jan 9;67(1):87-107
references.pmid: 14668113
references.citation: Int Arch Allergy Immunol. 2001 Jan-Mar;124(1-3):109-12
references.pmid: 11306943
references.citation: Toxicol Sci. 2007 Nov;100(1):203-14
references.pmid: 17660506
references.citation: Part Fibre Toxicol. 2006 Nov 29;3:15
references.pmid: 17134509
references.citation: Toxicol Sci. 2004 Jan;77(1):117-25
references.pmid: 14514968
references.citation: Am J Respir Cell Mol Biol. 2007 Sep;37(3):300-8
references.pmid: 17496151
references.citation: Am J Respir Cell Mol Biol. 1990 Nov;3(5):507-11
references.pmid: 2223105
references.citation: Toxicol Sci. 2004 Jan;77(1):126-34
references.pmid: 14514958
references.citation: J Exp Med. 2001 Sep 17;194(6):809-21
references.pmid: 11560996